by nms-sync | Nov 2, 2023 | News
NERVIANO, IT and BOSTON, Mass, November 2, 2023 – Nerviano Medical Sciences S.r.l., a part of NMS Group S.p.A. (NMS Group) and Nerviano Medical Sciences, Inc., a wholly owned subsidiary of NMS Group, focused on the discovery and early development of oncology...
by nms-sync | Oct 12, 2023 | News
Nerviano Medical Sciences Presents Preliminary, Encouraging Clinical Phase 1 Data for PARP-1 Selective Inhibitor at the 35th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
NERVIANO, IT and BOSTON, Mass, October 12, 2023...
by nms-sync | Oct 9, 2023 | News
We are attending the 2023 BIO Europe partnering event in Munich, Germany.
NMS Group- Nerviano Medical Sciences will participate to the 2023 BIO Europe partnering event, which will be held in
Munich from November 6th to 8th, 2023 and
online from November...
by nms-sync | Oct 2, 2023 | News
NERVIANO, IT and BOSTON, Mass, October 2, 2023 – Nerviano Medical Sciences S.r.l., a part of NMS Group S.p.A. (NMS Group) and Nerviano Medical Sciences, Inc., a wholly owned subsidiary of NMS Group, focused on the discovery and early development of oncology...
by nms-sync | Sep 25, 2023 | News
September 25th, 2023
Nerviano Medical Sciences S.r.l., a member of NMS Group S.p.A and a clinical stage biotech discovering and developing innovative therapies for the treatment of cancer, is proud to announce its participation to the World ADC 2023 summit...
by nms-sync | Sep 21, 2023 | News
Nerviano Medical Sciences (NMS), una Biotech focalizzata sulla ricerca e sviluppo di farmaci Oncologici innovativi, partecipa alla Settimana Europea delle Biotecnologie (European Biotech Week – EBW), giunta quest’anno alla sua XI edizione.
...
Welcome and Check out our new motion picture!
Recent Comments